资讯

Stocktwits on MSN6 小时
ResMed Draws Analyst Skepticism After Apnimed Announces Positive Results From ...
Analysts expect a negative impact on ResMed Inc. (RMD) after privately held pharmaceutical company and rival Apnimed, Inc.